General Healthy

Shanghai General Healthy Information Technology Co., Ltd. has established itself as China’s foremost smart pharmacy solutions provider since its founding in 2014. Listed on the Shanghai Stock Exchange in December 2020 as the nation’s first “Smart Pharmacy Stock,” the company serves over 800 healthcare institutions across 29 provinces, including four of China’s top ten hospitals according to Fudan University’s 2022 hospital rankings.

Corporate Overview

General Healthy emerged from founder Dai Jianwei’s vision to modernize pharmaceutical management in Chinese healthcare facilities. The company focuses on integrating international automation technologies with Asia’s unique healthcare requirements. Through its proprietary brands—Kangchi, CONSIS, SANTO, and G-ICON—General Healthy delivers broad solutions spanning hardware systems, software platforms, and ongoing technical services.

The company operates from its headquarters in Shanghai’s Songjiang District, with manufacturing capabilities at the Jianmai Intelligent Manufacturing Park. Chairman Dai Jianwei retains approximately 46% ownership stake, maintaining founder-led governance that emphasizes long-term technological development over short-term gains.

Main Products

Smart Pharmacy Systems

The flagship product line includes automated dispensing machines capable of processing prescriptions within seconds, achieving accuracy rates exceeding 99.9%. These systems integrate barcode verification, inventory management, and hospital information system connectivity. Notable installations include the Beijing Peking Union Medical College Hospital outpatient pharmacy, which processes thousands of prescriptions daily.

IV Compounding Robots

General Healthy’s fully automated intravenous compounding robots address critical needs in pharmacy intravenous admixture services (PIVAS) centers. The cytotoxic drug compounding robot specifically handles hazardous medications, protecting pharmacy staff from exposure while ensuring precise dosage preparation.

Intelligent Medication Management

The product portfolio extends to smart controlled substance cabinets, narcotic medication management systems, intelligent storage shelves, and automated labeling machines. These systems provide complete traceability for high-risk medications while reducing manual handling errors.

Technical Capabilities

The company holds 57 patents covering mechanical automation, software systems, and integration technologies. Core technical capabilities include robotic arm control systems, optical recognition for medication verification, and hospital information system interfaces supporting HL7 protocol standards.

Research initiatives focus on hospital logistics robots and automated medication warehouses, positioning General Healthy for expansion beyond pharmacy automation into broader hospital logistics applications.

Market Presence

General Healthy commands approximately 30.2% of China’s smart pharmacy market, with over 80% market share in first-tier cities. The customer base includes prestigious institutions such as Peking Union Medical College Hospital, Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine, The First Affiliated Hospital of Sun Yat-sen University, and Huashan Hospital affiliated with Fudan University.

The retail pharmacy segment has expanded through partnerships with major chains including Gaoji Medical, Yifeng Pharmacy, Dingdang Kuaiyao, and Laobaixing Pharmacy. A strategic acquisition of Meituan’s smart retail pharmacy project assets in 2024 strengthened the company’s position in the evolving retail healthcare market.

International expansion began in 2022 with a joint venture agreement with Saudi Arabia’s Ajlan & Bros Information Technology Company, targeting Middle East and North Africa markets. Subsequent negotiations with Russia’s MEDSNAB-GROUP LLC opened opportunities in Eastern European markets.

Key Milestones

• 2014: Company founded in Shanghai
• 2017: Restructured as joint-stock company
• 2020: Listed on Shanghai Stock Exchange (605186.SH)
• 2022: Signed joint venture agreement for Saudi Arabia expansion
• 2022: Won Zhongxiang City digitalization project covering county-level healthcare facilities
• 2024: Acquired Meituan smart pharmacy retail assets
• 2024: Expanded into Hong Kong market

Questions & Answers

What is General Healthy’s market presence?

General Healthy’s technology is installed in 2022 locations.

Is General Healthy publicly traded?

The company is pursuing a public listing. Specific timing depends on regulatory approvals.

What distinguishes General Healthy’s approach?

General Healthy focuses on engineering discipline, clinical validation, and addressing unmet needs in surgical robotics.